Strategy Backtests
Every strategy we test — winners and losers — published with full equity curves, drawdowns and honest verdicts. Real Dukascopy tick data, commission included, out-of-sample validated.
USD/JPY Risk-Off Rebound
Dukascopy Tick Data · In-sample 2017–2022 · Out-of-sample 2022–2026 · commission included
Index Gap-and-Go (S&P 500)
M1 Bar Data · In-sample 2017–2022 · Out-of-sample 2022–2026 · spread-only costs, no commission
Gotobi Tokyo Fix — EURJPY Transmission
Dukascopy Tick Data · In-sample 2019–2022 · Out-of-sample 2022–2026 · commission included
Small-Edges Cross-Family Portfolio
Dukascopy Tick Data · In-sample 2019–2022 · Out-of-sample 2022–2026 · commission included
Asian Session Range Breakout
Dukascopy Tick Data · In-sample 2019–2022 · Out-of-sample 2022–2026 · commission included
WMR Fix Reversal
Dukascopy Tick Data · In-sample 2019–2022 · Out-of-sample 2022–2026 · commission included
USDJPY Triple-Swap Wednesday
Dukascopy Tick Data · In-sample 2019–2022 · Out-of-sample 2022–2026 · commission included
BTC Donchian Trend
Dukascopy tick data priced at IC Markets costs · In-sample 2019–2022 · Out-of-sample 2022–2026 · commission and swap included
Gotobi Tokyo Fix
Dukascopy Tick Data · In-sample 2019–2022 · Out-of-sample 2022–2026 · commission included
The exact rules of every strategy we've put on trial, how we tested each one, and what the data showed. 12 case files so far, free with your email.
Rejected before the out-of-sample stage
These ideas died in research or in-sample testing, before ever touching held-out data. No equity curves to show, on purpose. Each write-up explains what killed it.